Table 7.6g

Immunosuppression Use for Maintenance Between Discharge

		Year of Transplant
		1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Transplants		156	220	305	305	375	344	420	343	293	261
Tx with Follow-up Immunosuppression Info		110	167	220	245	272	258	320	255	221	206
Corticosteroids	Any in Category	100.0%	100.0%	98.6%	98.8%	94.5%	78.7%	73.8%	74.9%	71.0%	59.2%
Corticosteroids	Steroids	100.0%	100.0%	98.6%	98.8%	94.5%	78.7%	73.8%	74.9%	71.0%	59.2%
Cyclosporine	Any in Category	32.7%	14.4%	16.4%	15.1%	15.4%	11.2%	8.1%	6.7%	6.8%	5.8%
	Sandimmmune	5.5%	2.4%	3.2%	0.8%	1.1%	0.0%	0.3%	0.0%	0.5%	0.5%
	Neoral	27.3%	12.0%	12.3%	12.7%	12.1%	9.3%	5.0%	6.3%	6.3%	5.3%
	Gengraf	0.0%	0.0%	0.9%	0.8%	2.2%	1.6%	2.8%	0.4%	0.0%	0.0%
	Eon	0.0%	0.0%	0.0%	0.8%	0.0%	0.4%	0.0%	0.0%	0.0%	0.0%
Tacrolimus	Any in Category	76.4%	91.0%	91.8%	91.8%	87.1%	82.9%	87.2%	92.5%	91.9%	92.7%
Tacrolimus	Tacrolimus	76.4%	91.0%	91.8%	91.8%	87.1%	82.9%	87.2%	92.5%	91.9%	92.7%
Antimetabolites	Any in Category	99.1%	95.2%	84.5%	80.4%	80.5%	84.9%	82.5%	90.6%	87.3%	90.3%
	Mycophenolate Mofetil	89.1%	86.2%	78.6%	78.0%	78.3%	81.0%	79.4%	84.3%	75.6%	75.7%
	Mycophenolate Sodium	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.2%	4.3%	8.6%	12.1%
	Azathioprine	10.0%	9.0%	5.9%	2.4%	2.2%	3.5%	0.3%	2.0%	1.8%	1.0%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.4%	0.6%	0.0%	1.4%	1.5%
	Cytoxan	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
mTOR Inhibitors	Any in Category	0.9%	7.2%	24.5%	30.6%	31.6%	27.5%	25.6%	19.2%	17.2%	18.9%
	Sirolimus	0.9%	7.2%	24.5%	30.6%	31.6%	27.5%	25.6%	19.2%	17.2%	18.9%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%